FSI Stanford Events

The Cost-effectiveness of Osteoporosis Treatment in High-risk Osteoporotic Women

CHP/PCOR Research in Progress Seminar

Date and Time
April 20, 2005
1:30 PM - 3:00 PM

Availability
Open to the public
No RSVP required

Speakers
Hau Liu - Stanford University
Kaleb D. Michaud

Location
Health Research & Policy Building
(Redwood Building), Room T138-B
259 Campus Drive
Stanford University
Stanford, CA 94305
» Directions/Map

Parent Research Projects

Osteoporosis and Cost-Effectiveness
Amber Barnato
Insurance Type, Treatment and 28 Day Mortality of High Risk Infants in California
Alex Khalessi
Cost-Effectiveness Analyses: Cost-Effectiveness of Vaccinating College Freshmen against Meningitis
Gillian D. Sanders, P Bilir, C Rydzak
The Cost-effectiveness of Different Drugs for the Treatment of Hypertension: An Economic Analysis of ALLHAT
Paul A. Heidenreich

The Cost-effectiveness of Therapy With Teriparatide and Alendronate in Women With Severe Osteoporosis
Hau Liu, Kaleb D. Michaud, Smita Nayak, David Karpf, Douglas K. Owens, Alan M. Garber
Archives of Internal Medicine vol. 166, 11 (2006)
Cost-Effectiveness Analysis of Photodynamic Therapy for Treatment of High Grade Dysplasia in Barrett's Esophagus
Rohini. Vij, G Triadafilopoulos, Douglas K. Owens, P Kunz, Gillian D. Sanders
Gastrointestinal Endoscopy (2003)
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003
Randall S. Stafford, R Drieling, A Hersh
Archives of Internal Medicine vol. 164, 14 (2004)
Effectiveness and Cost-Effectiveness of Implantable Cardioverter Defibrillators in the Treatment of Ventricular Arrhythmias among Medicare Beneficiaries
JP Weiss, O Sayina, Kathryn M. McDonald, Mark B. McClellan, Mark A. Hlatky
American Journal of Medicine vol. 112 (2002)